Arovella Therapeutics Limited (ASX:ALA) has disclosed a change in the relevant interests of director David John Williams, following an on-market purchase of 180,000 ordinary shares by Moggs Creek Pty Ltd as trustee for the Moggs Creek Superannuation Fund at $0.049999 per share on 16 November 2026.
Key Points
- Director David John Williams acquired 180,000 ordinary shares on-market through Moggs Creek Pty Ltd ATF Moggs Creek Superannuation Fund on 16 November 2026
- The shares were purchased at $0.049999 per share via an on-market transaction
- Following the acquisition, Moggs Creek Pty Ltd ATF Moggs Creek Superannuation Fund holds 473,354 ordinary shares and 8,000,000 performance rights
- Lawn Views Pty Ltd ATF Angela Williams Family Trust continues to hold 200,000 ordinary shares, unchanged
Details of the On-Market Share Purchase
According to the filing, the transaction was conducted as an on-market purchase dated 16 November 2026, with 180,000 ordinary shares acquired at a price of $0.049999 per share. The acquiring entity was Moggs Creek Pty Ltd as trustee for the Moggs Creek Superannuation Fund. The filing confirms no securities were disposed of as part of this transaction. The interest held by David John Williams is classified as indirect, with the director holding the power to exercise or control the exercise of the right to vote or dispose of shares in the relevant entities.
Securities Held Before and After the Change
Prior to the transaction, Moggs Creek Pty Ltd ATF Moggs Creek Superannuation Fund held 293,354 ordinary shares and 8,000,000 performance rights. Following the acquisition of 180,000 ordinary shares, that entity's holding increased to 473,354 ordinary shares, with the 8,000,000 performance rights remaining unchanged. Separately, Lawn Views Pty Ltd ATF Angela Williams Family Trust held 200,000 ordinary shares before and after the change, with no alteration to that holding disclosed in the filing.
Closed Period and Contract Interest Disclosures
The filing states that the interests in securities were not traded during a closed period where prior written clearance was required. No changes to the director's interests in contracts were disclosed, with all relevant fields in Part 2 of the notice recorded as not applicable. The previous director's interest notice for David John Williams was dated 16 November 2026, as stated in the filing. No changes to contractual interests or other notifiable interests were recorded in connection with this update.




Please wait processing your request...